Survival analysis further suggested regulatory correlations: elevated expression of FAM18A-AS1 and miR-21 was associated with poor prognosis in low-grade glioma, and high expression of EGFR, WEE1, MAP2K3, JA1, and EPHA2 was associated with poor prognosis. The gene discussed is MAP2K3; the disease is central nervous system cancer.